Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          Stakeholders Will Be Able to Comment on First Two Volumes of the Intentional Adulteration Rule Draft Guidance TogetherCFSAN Constituent Updates Stakeholders Will Be Able to Comment on First Two Volumes of the Intentional Adulteration Rule Draft Guidance Together
  
  	
    Share
    Post
    Linkedin

    Email
    PrintConstituent Update

December 4, 2018

If you plan to comment on the first installment of the three-part draft Intentional Adulteration (IA) Rule guidance, you will have an additional opportunity to do so. Although the closing date for public comment on the first installment is December 17, the U.S. Food and Drug Administration (FDA) intends to ask for comments on both the first and upcoming second volumes during the comment period after the second installment of the draft guidance is issued.

In June, the FDA released the first installment of the draft guidance designed to support compliance with the IA Rule under the FDA Food Safety Modernization Act (FSMA). This rule is aimed at preventing intentional adulteration of food designed to cause wide-scale harm to public health, including terrorism targeting the food supply.

The second installment of the draft guidance will be presented in early 2019 alongside the first installment, so that the public can view content from both together. The FDA wants to give stakeholders an opportunity to consider the available guidance materials when drafting their comments. When the second installment is published, there will be an additional 120 days to comment on the expanded guidance. It’s important to note that regardless of closing dates, the public may comment on an FDA guidance document at any time.

The first compliance date for larger businesses under the IA Rule is July 26, 2019.

**For More Information**

Draft Guidance for Industry: Mitigation Strategies to Protect Food Against Intentional Adulteration
	FSMA Final Rule for Mitigation Strategies to Protect Food Against Intentional Adulteration

                                                                                  Content current as of:
      12/04/2018
              
              
Regulated Product(s)
		 Food & BeveragesCFSAN Constituent Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop